Solvay Future Growth
Future criteria checks 4/6
Solvay is forecast to grow earnings and revenue by 43% and 0.3% per annum respectively. EPS is expected to grow by 39.7% per annum. Return on equity is forecast to be 37.5% in 3 years.
Key information
43.0%
Earnings growth rate
39.7%
EPS growth rate
Chemicals earnings growth | 15.1% |
Revenue growth rate | 0.3% |
Future return on equity | 37.5% |
Analyst coverage | Good |
Last updated | 09 Dec 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,941 | 447 | 380 | 824 | 9 |
12/31/2025 | 4,776 | 389 | 336 | 762 | 11 |
12/31/2024 | 4,673 | 281 | 307 | 706 | 11 |
9/30/2024 | 5,217 | -64 | 196 | 618 | N/A |
6/30/2024 | 5,337 | 18 | 404 | 1,102 | N/A |
3/31/2024 | 5,570 | 127 | 804 | 1,731 | N/A |
12/31/2023 | 6,024 | -37 | 847 | 1,911 | N/A |
9/30/2023 | 497 | -384 | 1,162 | 2,372 | N/A |
6/30/2023 | 3,542 | -34 | 1,178 | 2,252 | N/A |
3/31/2023 | 6,038 | 495 | 977 | 1,945 | N/A |
12/31/2022 | 7,979 | 889 | 1,097 | 2,006 | N/A |
9/30/2022 | 15,442 | 1,859 | 998 | 1,775 | N/A |
6/30/2022 | 13,895 | 1,659 | 1,001 | 1,723 | N/A |
3/31/2022 | 12,523 | 1,176 | 897 | 1,578 | N/A |
12/31/2021 | 11,434 | 943 | 863 | 1,499 | N/A |
9/30/2021 | 10,575 | 648 | 927 | 1,440 | N/A |
6/30/2021 | 9,982 | 608 | 1,028 | 1,482 | N/A |
3/31/2021 | 9,631 | -1,168 | 1,158 | 1,603 | N/A |
12/31/2020 | 9,714 | -1,125 | 707 | 1,242 | N/A |
9/30/2020 | 10,006 | -1,216 | 771 | 1,408 | N/A |
6/30/2020 | 10,514 | -1,872 | 726 | 1,496 | N/A |
3/31/2020 | 11,055 | -134 | 742 | 1,585 | N/A |
12/31/2019 | 11,227 | -118 | 958 | 1,815 | N/A |
9/30/2019 | 11,347 | 111 | 1,223 | 2,081 | N/A |
6/30/2019 | 11,409 | 764 | 1,039 | 1,863 | N/A |
3/31/2019 | 11,349 | 767 | 741 | 1,572 | N/A |
12/31/2018 | 11,299 | 676 | 887 | 1,720 | N/A |
9/30/2018 | 11,187 | 775 | 737 | 1,582 | N/A |
6/30/2018 | 10,987 | 748 | N/A | 1,623 | N/A |
3/31/2018 | 10,953 | 730 | N/A | 1,649 | N/A |
12/31/2017 | 10,984 | 820 | N/A | 1,590 | N/A |
9/30/2017 | 10,851 | 771 | N/A | 1,602 | N/A |
6/30/2017 | 10,694 | 765 | N/A | 1,718 | N/A |
3/31/2017 | 10,057 | 717 | N/A | 1,800 | N/A |
12/31/2016 | 10,044 | 539 | N/A | 1,788 | N/A |
9/30/2016 | 9,168 | 317 | N/A | 1,694 | N/A |
6/30/2016 | 9,512 | 248 | N/A | 1,572 | N/A |
3/31/2016 | 10,146 | 220 | N/A | 1,626 | N/A |
12/31/2015 | 10,083 | 355 | N/A | 1,289 | N/A |
9/30/2015 | 11,068 | 325 | N/A | 1,591 | N/A |
6/30/2015 | 10,929 | 311 | N/A | 1,554 | N/A |
3/31/2015 | 10,793 | 376 | N/A | 1,436 | N/A |
12/31/2014 | 10,629 | 326 | N/A | 1,621 | N/A |
9/30/2014 | 10,425 | 317 | N/A | 1,275 | N/A |
6/30/2014 | 10,222 | 298 | N/A | 1,332 | N/A |
3/31/2014 | 10,086 | 182 | N/A | 1,251 | N/A |
12/31/2013 | 10,150 | 164 | N/A | 1,299 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0NZR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: 0NZR is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0NZR is expected to become profitable in the next 3 years.
Revenue vs Market: 0NZR's revenue (0.3% per year) is forecast to grow slower than the UK market (3.6% per year).
High Growth Revenue: 0NZR's revenue (0.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0NZR's Return on Equity is forecast to be high in 3 years time (37.5%)